Novelix Pharmaceuticals Limited (BOM:536565)

Novelix Pharmaceuticals Revenue

Novelix Pharmaceuticals had revenue of 363.91M INR in the quarter ending September 30, 2025, with 839.45% growth. This brings the company's revenue in the last twelve months to 849.03M, up 1,293.70% year-over-year. In the fiscal year ending March 31, 2025, Novelix Pharmaceuticals had annual revenue of 307.33M with 578.26% growth.

• Revenue (ttm): 849.03M
• Revenue Growth: +1,293.70%
• P/S Ratio: 1.16
• Revenue / Employee: 106.13M
• Employees: 8
• Market Cap: 987.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	307.33M	262.02M	578.26%
Mar 31, 2024	45.31M	26.11M	135.96%
Mar 31, 2023	19.20M	-69.92M	-78.45%
Mar 31, 2022	89.13M	-6.72M	-7.01%
Mar 31, 2021	95.85M	-12.58M	-11.60%